Is azithromycin better than current first-line treatments
for typhoid and paratyphoid fever? Evidence update - Summary of a Cochrane Review

LSTM Department of Tropical Disease Biology

Is azithromycin better than current first-line treatments for typhoid and paratyphoid fever? Evidence update - Summary of a Cochrane Review

LSTM Department of Tropical Disease Biology

Tropical Disease Biology

Research output: Other contribution

Abstract

Azithromycin is at least as good as fluoroquinolones, but more expensive.

Original language	English
Publisher	Liverpool School of Tropical Medicine
Publication status	Published - 1 Jan 2010

Access to Document

OtherInfDiseases CD006083 Jan10 Final 000Final published version, 145 KBLicence: CC BY-ND

Cite this

@misc{354973fc2ce5471ab9a61af064cfc39d,

title = "Is azithromycin better than current first-line treatments for typhoid and paratyphoid fever? Evidence update - Summary of a Cochrane Review",

abstract = "Azithromycin is at least as good as fluoroquinolones, but more expensive.",

author = "{Department of Tropical Disease Biology}, LSTM",

year = "2010",

month = jan,

day = "1",

language = "English",

publisher = "Liverpool School of Tropical Medicine",

type = "Other",

}

TY - GEN

T1 - Is azithromycin better than current first-line treatments for typhoid and paratyphoid fever? Evidence update - Summary of a Cochrane Review

AU - Department of Tropical Disease Biology, LSTM

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Azithromycin is at least as good as fluoroquinolones, but more expensive.

AB - Azithromycin is at least as good as fluoroquinolones, but more expensive.

M3 - Other contribution

PB - Liverpool School of Tropical Medicine

ER -

Is azithromycin better than current first-line treatments for typhoid and paratyphoid fever? Evidence update - Summary of a Cochrane Review

Abstract

Access to Document

Fingerprint

Cite this